Unidade de Investigación en Cardioloxía Celular e Molecular
C.C.M.
![Foto de Unidade de Investigación en Cardioloxía Celular e Molecular](/img/grupo.png)
![Foto de Universidade de São Paulo](/img/noimage_org.png)
Universidade de São Paulo
São Paulo, BrasilPublikationen in Zusammenarbeit mit Forschern von Universidade de São Paulo (4)
2022
-
Efficacy of empagliflozin in heart failure with preserved versus mid-range ejection fraction: a pre-specified analysis of EMPEROR-Preserved
Nature Medicine, Vol. 28, Núm. 12, pp. 2512-2520
2021
-
Empagliflozin in heart failure with a preserved ejection fraction
New England Journal of Medicine, Vol. 385, Núm. 16, pp. 1451-1461
2020
-
Baseline characteristics of patients with heart failure with preserved ejection fraction in the EMPEROR-Preserved trial
European Journal of Heart Failure, Vol. 22, Núm. 12, pp. 2383-2392
2015
-
The patient perspective: Quality of life in advanced heart failure with frequent hospitalisations
International Journal of Cardiology, Vol. 191, pp. 256-264